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Abstract 
In meta-analysis, the random-effects models are standard tools to address between-study 
heterogeneity in evidence synthesis analyses. For the random-effects distribution models, 
the normal distribution model has been adopted in most systematic reviews due to its 
computational and conceptual simplicity. However, the restrictive model assumption 
might have serious influences on the overall conclusions in practices. In this article, we 
first provide two examples of real-world evidence that clearly show that the normal 
distribution assumption is unsuitable. To address the model restriction problem, we 
propose alternative flexible random-effects models that can flexibly regulate skewness, 
kurtosis and tailweight: skew normal distribution, skew t-distribution, asymmetric 
Subbotin distribution, Jones–Faddy distribution, and sinh–arcsinh distribution. We also 
developed a R package, flexmeta, that can easily perform these methods. Using the 
flexible random-effects distribution models, the results of the two meta-analyses were 
markedly altered, potentially influencing the overall conclusions of these systematic 
reviews. The flexible methods and computational tools can provide more precise evidence, 
and these methods would be recommended at least as sensitivity analysis tools to assess 
the influence of the normal distribution assumption of the random-effects model. 
 
Key words: meta-analysis; random-effects model; flexible probability distribution; model 
inadequacy; predictive distribution. 
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1. Introduction 
In meta-analysis in medical studies, random-effects models have been the primary 
statistical tools for quantitative evaluation of treatment effects that account for between-
studies heterogeneity 1,2. Conventionally, the normal distribution assumption has been 
adopted in most systematic reviews due to its computational and conceptual simplicity 2,3. 
However, the shape of the random-effects distribution reflects how the treatment effects 
parameters (e.g., mean difference, log relative risk) are distributed in the target population, 
and are directly associated with the fundamental heterogeneity of treatment effects. If the 
normal distribution assumption diverges drastically from the true heterogeneous structure, 
the overall results of the meta-analyses may be misleading. In addition, in recent studies, 
prediction intervals have been gaining prominence in meta-analyses as a means to 
quantify heterogeneity and effectiveness in real-world uses of the treatment 4,5. Because 
the prediction interval is constructed by the estimated random-effects distribution, it 
should be directly influenced by the form of the distribution assumptions.  
Several papers have discussed the flawed uses of the normal distribution model 
in meta-analyses 6-9. In particular, simulation-based evidence from Kontopantelis and 
Reeves 7 and Rubio-Aparicio et al. 8 showed the validity of inference was violated when 
the true effect size distribution diverged drastically from the normal distribution. 
Although classical transformation methods have been conventionally applied, these 
methods have the same restriction after these transformations. In addition, the back-
transformation results can provide seriously misleading results under certain situations 9. 
To date, only a few effective methods have been developed to address this issue, and there 
are no useful statistical packages that can be handled by non-statisticians. Also, there is a 
lack of real-world evidence that clearly demonstrates the relevance of this issue. 
In this article, we propose random-effects meta-analysis methods with flexible 
2 
 
 
distribution models that can flexibly express skewness, kurtosis, and tailweight: (1) skew 
normal distribution 10,11, (2) skew t-distribution 11,12, (3) asymmetric Subbotin distribution 
11,13, (4) Jones–Faddy distribution 14, and (5) sinh–arcsinh distribution 15. Via application 
of these five flexible random-effects distribution models to two recently published 
systematic reviews 16,17, we will demonstrate that the overall conclusions and 
interpretations of meta-analyses can be dramatically altered if the normal distribution 
assumption is not suitable. In addition, we provide a new R package, flexmeta, that can 
perform meta-analysis with simple code using the flexible random-effects distributions 
(available at https://github.com/nomahi/flexmeta). We will explicitly show that the 
implicit uses of the normal distribution assumption might yield misleading results, and 
that our flexible alternative distributions may provide more valid conclusions for health 
technology assessments and policy making. 
 
2. Motivating examples: Is the normal distribution assumption appropriate? 
We searched for recently published systematic reviews in leading medical journals (e.g., 
BMJ, JAMA), and found two examples 16,17 that clearly demonstrated the unsuitability of 
the normal distribution assumption. The first example is a meta-analysis by Rubinstein et 
al. 16 assessing the benefits and harms of spinal manipulative therapy (SMT) for the 
treatment of chronic lower back pain. In Figure 1(a), we present a forest plot of their 
meta-analysis of 18 randomized controlled trials assessing the pain at 1 month (0–100; 0 
= no pain, 100 = maximum pain) for SMT (N = 1629) vs. recommended therapies (N = 
1526). The effect measure was the mean difference (MD). Using the ordinary random-
effects meta-analysis method based on the normal random-effects distribution, we 
identified a substantial heterogeneity of the treatment effects, I2 = 92%, τ2 = 112.20. The 
between-studies heterogeneity should be addressed in synthesis analysis. However, most 
3 
 
 
of the MD estimates fell within a relatively narrow range around the mean, although a 
small number exhibited larger effect sizes. This might imply that the true MD distribution 
is a skewed, heavy-tailed, and sharply-peaked distribution. Although the average MD was 
estimated as −3.17 (95%CI: −7.85, 1.51) by the DerSimonian-Laird method 3, the point 
and interval estimates depend on the normal distribution assumption. 
The second example is a meta-analysis by Koutoukidis et al. 17 aimed at 
estimating the association of weight loss interventions with biomarkers of liver disease in 
nonalcoholic fatty liver disease. In Figure 1(b), we also present a forest plot of their meta-
analysis of 21 randomized controlled trials that assess the weight loss (kg) for more-
intensive weight loss interventions (N = 1496) vs. no or lower-intensity weight loss 
interventions (N = 1062). Again, the effect measure was the MD, and we identified a 
substantial heterogeneity of the treatment effects: I2 = 95%, τ2 = 12.45. In this case, the 
MD estimates were not symmetrically distributed, and a certain number of trials exhibited 
a larger intervention effect than the average MD of −3.51 (95%CI: −5.03, −2.00). Thus, 
the true MD distribution would be a skewed, heavy-tailed distribution. In particular, in 
predicting the intervention effect of a future trial, the normal distribution model would 
not suitably fit this dataset. Although the ordinary 95% Higgins–Thompson–Spiegelhalter 
(HTS) prediction interval 5 was (−11.02, 3.99), it might not express the true nature of the 
intervention effects in the target population. 
Note that the two datasets involve several duplicated summary statistics from the 
same trials. These analyses are essentially inadequate because the correlations among 
multiple outcome measures within a single study are not addressed 1. In the following 
sections, we used the original datasets from the two papers for comparability of the results, 
but we provided some sensitivity analyses to assess the sensitivity at e-Appendix A in 
Supporting Information. 
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3. The flexible random-effects distribution models 
To address the restriction problem of the normal distribution, we propose random-effects 
meta-analysis methods using five flexible random-effects distribution models. For the 
notation, we consider that there are 𝐾  studies to be synthesized, and that 𝑌௜ ሺ𝑖 ൌ1,2, … ,𝐾ሻ  is the estimated treatment effect measure in the 𝑖 th study, e.g., mean 
difference, odds ratio, and hazard ratio; the ratio measures are typically transformed to 
logarithmic scales. The random-effects models considered here are then defined as 
𝑌௜~𝑁ሺ𝜃௜ ,𝜎௜ଶሻ       (*) 
𝜃௜~𝐹ሺ𝜃ሻ 
where 𝜃௜ is the true effect size of the 𝑖th study, and 𝜎௜ଶ is the within-studies variance, 
which is usually assumed to be known and fixed to valid estimates. Also, 𝐹ሺ𝜃ሻ 
corresponds to the random-effects distribution that expresses the heterogeneous 
probability distribution of 𝜃௜. For the conventional normal-normal random-effects model, 
𝐹ሺ𝜃ሻ corresponds to a normal distribution. The predictive interval for future study 4 is 
substantially constructed based on the random-effects distribution 𝐹ሺ𝜃ሻ. To overcome 
the limitations on the expressive ability of the normal distribution, our proposal is to adopt 
alternative flexible probability distributions. Currently, due to developments in statistical 
distribution theory, various flexible probability distributions are available. Here, we chose 
five representatives of the newest recently developed distributions. In Figure 2, we 
present some examples of these five distributions and their ability to express various 
shapes.  
 
3.1 Skew normal distribution: SN(𝜉,𝜔,𝛼) 
The skew normal distribution 10,11 is a generalized version of the conventional normal 
distribution that allows for skewness. The probability density function is 
5 
 
 
𝑝ሺ𝜃|𝜉,𝜔,𝛼ሻ ൌ 2𝜔𝜙 ൬𝜃 െ 𝜉𝜔 ൰Φ൬𝛼ሺ𝜃 െ 𝜉ሻ𝜔 ൰ 
where 𝜙ሺ𝜃ሻ  and Φሺ𝜃ሻ  are, respectively, the probability density and cumulative 
distribution functions of the standard normal distribution N(0, 1). 𝜉  is the location 
parameter that regulates the center location, and ω (> 0) is the scale parameter that 
regulates the dispersion of the distribution; we use these notations similarly for the 
following four distributions as well; in the graphical displays in Figure 2, we set these 
parameters to 𝜉 ൌ 0 and 𝜔 ൌ 1, consistently. 𝛼 is the skewness parameter that adjusts 
the skewness; the distribution is positively (negatively) skewed for 𝛼 ൐ 0  (𝛼 ൏ 0). 
When 𝛼 ൌ 0, it reduces to a normal distribution N(𝜉,𝜔). The mean and variance of this 
distribution are Eሾ𝜃ሿ ൌ 𝜉 ൅ 𝜔𝑏𝛿 Vሾ𝜃ሿ ൌ 𝜔ଶሾ1 െ ሺ𝑏𝛿ሻଶሿ 
where 
𝑏 ൌ ඨ2𝜋 , 𝛿 ൌ 𝛼√1 ൅ 𝛼ଶ 
In Figure 2(a), we present probability density functions of the skew normal distribution 
with 𝛼 ൌ 0,1,2,4,6,8 . It can flexibly express skew-shaped distributions, but has 
limitations in expressing kurtosis and tailweight. 
 
3.2 Skew t-distribution: ST(𝜉,𝜔, 𝜈,𝛼) 
The skew t-distribution 11,12 is also a generalized version of the conventional Student t-
distribution that allows for skewness. The t-distribution can express heavy tailweight and 
a wide range of kurtosis relative to the normal distribution via varying the degree of 
freedom ν (> 0). The probability density function is 
6 
 
 
𝑝ሺ𝜃|𝜉,𝜔, 𝜈,𝛼ሻ ൌ 2𝜔𝑓௧ ൬𝜃 െ 𝜉𝜔 ฬ 𝜈൰ 𝐹௧ ቌ𝛼ሺ𝜃 െ 𝜉ሻ𝜔 ඨ 𝜔ଶሺ𝜈 ൅ 1ሻ𝜈𝜔ଶ ൅ ሺ𝜃 െ 𝜉ሻଶቮ 𝜈 ൅ 1ቍ 
where 𝑓௧ሺ𝜃|𝜈ሻ and 𝐹௧ሺ𝜃|𝜈ሻ are, respectively, the probability density and cumulative 
distribution functions of the Student t-distribution with 𝜈 (> 0) degrees of freedom. 𝜉 
is the location parameter that regulates the center location, and ω (> 0) is the scale 
parameter that regulates the dispersion of the distribution. 𝛼 is the skewness parameter 
that adjusts the skewness and the distribution is positively (negatively) skewed for 𝛼 ൐0 (𝛼 ൏ 0). When 𝛼 ൌ 0 , it reduces to the Student t-distribution with 𝜈 degrees of 
freedom. The mean and variance of this distribution are Eሾ𝜃ሿ ൌ 𝜉 ൅ 𝜔𝑏ఔ𝛿 Vሾ𝜃ሿ ൌ 𝜔ଶ ቂ 𝜈𝜈 െ 2 െ ሺ𝑏ఔ𝛿ሻଶቃ 
where 
𝑏ఔ ൌ √𝜈Γሺሺ𝜈 െ 1ሻ 2ሻ⁄√𝜋Γሺ𝜈 2ሻ⁄ , 𝛿 ൌ 𝛼√1 ൅ 𝛼ଶ 
The skew t-distribution can express flexible shapes by controlling the degree of freedom, 
compared with skew normal distribution, especially for the kurtosis and tailweight. In 
Figure 2(b)(c), we present the probability density functions of the skew t-distribution with 
𝛼 ൌ 1,2,4,5,10,20 with 𝜈 ൌ 2,8. The skew t-distribution can express flexible shapes by 
controlling the degree of freedom, relative to the skew normal distribution, especially for 
kurtosis and tailweight. 
 
3.3 Asymmetric Subbotin distribution (Type II): AS2(𝜉,𝜔, 𝜈,𝛼) 
Subbotin 18 proposed a symmetric probability distribution that can regulate the kurtosis 
and tail thickness flexibly. The probability density function of the Subbotin distribution 
7 
 
 
with 𝜈 (> 0) degrees of freedom is  
𝑓ௌሺ𝜃|𝜈ሻ ൌ 12𝜈ଵ ఔ⁄ Γሺ1 ൅ 1 𝜈⁄ ሻ expቆെ |𝜃|ఔ𝜈 ቇ 
Based on the form of the probability density function, this distribution includes a double 
exponential and trapezoidal-shaped distributions (for large 𝜈 ) as special cases. The 
location and scale can be regulated by linear transformation, and the distribution can 
flexibly express heavy and light tailweight. The asymmetric Subbotin distribution of type 
II (AS2) 13 is an extended version of this distribution, and the probability density function 
is 
𝑝ሺ𝜃|𝜉,𝜔, 𝜈,𝛼ሻ ൌ 2𝜔𝑓ௌ ൬𝜃 െ 𝜉𝜔 ฬ 𝜈൰ 𝐹ௌ ൬𝛼ሺ𝜃 െ 𝜉ሻ𝜔 ൰ 
where 
𝐹ௌሺ𝜃ሻ ൌ Φቆsgnሺ𝜃ሻ |𝜃|ఔ ଶ⁄ඥ𝜈 2⁄ ቇ 
𝜉 is the location parameter that regulates the center location, and ω is the scale parameter 
that regulates the dispersion of the distribution. The distribution is positively (negatively) 
skewed for 𝛼 ൐ 0 (𝛼 ൏ 0), and more kurtosed for smaller ν. The mean and variance of 
this distribution are Eሾ𝜃ሿ ൌ 𝜉 ൅ sgnሺ𝛼ሻ𝜔𝐶ఔ𝑄ఔ 
Vሾ𝜃ሿ ൌ ωଶ ቈ𝜈ଶ ఔ⁄ Γሺ3 𝜈⁄ ሻΓሺ1 𝜈⁄ ሻ െ ሺ𝐶ఔ𝑄ఔሻଶ቉ 
where 
𝐶ఔ ൌ 𝜈
ଵ ఔ⁄ Γሺ2 𝜈⁄ ሻ
Γሺ1 𝜈⁄ ሻ ,𝑄ఔ ൌ 2𝐹௧ ቀඥ4|𝛼|ఔ 𝜈⁄ ቚ 4 𝜈⁄ ቁ െ 1 
We present some examples of the AS2 distribution in Figure 2(d)(e), which clearly display 
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its flexible expression ability. As shown in these graphical displays, the AS2 distribution 
can express a sharp skew distribution, which can be seen as an asymmetric double 
exponential distribution. Also, it can express a more rounded shape, like the skew t-
distribution. 
 
3.4 Jones–Faddy distribution: JF(𝜉,𝜔,𝑎, 𝑏) 
Jones and Faddy 14 proposed another skewed version of the t-distribution, whose 
probability density function is expressed as 
𝑝ሺ𝜃|𝜉,𝜔, 𝜈,𝛼ሻ ൌ 1𝜔𝑓௃ி ൬𝜃 െ 𝜉𝜔 ฬ 𝑎, 𝑏൰ 
where 
𝑓௃ிሺ𝑧|𝑎, 𝑏ሻ ൌ 𝐶௔,௕ିଵ ൜1 ൅ 𝑧ሺ𝑎 ൅ 𝑏 ൅ 𝑧ଶሻଵ ଶ⁄ ൠ௔ାଵ ଶ⁄ ൜1 െ 𝑧ሺ𝑎 ൅ 𝑏 ൅ 𝑧ଶሻଵ ଶ⁄ ൠ௕ାଵ ଶ⁄  
𝐶௔,௕ ൌ 2௔ା௕ିଵ𝐵ሺ𝑎, 𝑏ሻሺ𝑎 ൅ 𝑏ሻଵ ଶ⁄  
where 𝐵ሺ𝑎, 𝑏ሻ is the beta function. The Jones–Faddy distribution regulates the skewness 
and kurtosis through two model parameters 𝑎 ሺ൐ 0ሻ and 𝑏 ሺ൐ 0ሻ. 𝜉 is the location 
parameter that regulates the center location, and ω (> 0) is the scale parameter, 
respectively. This distribution is positively (negatively) skewed for a > b (a < b). Also, it 
reduces to the t-distribution for 𝑎 ൌ 𝑏 , with 𝑎 ൅ 𝑏  degrees of freedom. It can also 
flexibly express various distributions including skewed, sharply-peaked, and/or heavy-
tailed shapes. Some examples are provided in Figure 2(f)(g). The mean and variance are Eሾ𝜃ሿ ൌ 𝜉 ൅ 𝜔𝜂௔,௕ 
Vሾ𝜃ሿ ൌ 𝜔ଶ ቈ𝑎 ൅ 𝑏4 ሺ𝑎 െ 𝑏ሻଶ ൅ 𝑎 ൅ 𝑏 െ 2ሺ𝑎 െ 1ሻሺ𝑏 െ 1ሻ െ 𝜂௔,௕ଶ቉ 
where 
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𝜂௔,௕ ൌ ሺ𝑎 െ 𝑏ሻ√𝑎 ൅ 𝑏2 Γሺ𝑎 െ 1 2⁄ ሻΓሺ𝑏 െ 1 2⁄ ሻΓሺ𝑎ሻΓሺ𝑏ሻ  
 
3.5 Sinh–arcsinh distribution: SAS(𝜉,𝜔, 𝛿, 𝜖) 
Jones and Pewsey 15 proposed a flexible unimodal four parameter distribution that is 
induced by sinh–arcsinh (SAS) transformation. The probability density function is 
𝑝ሺ𝜃|𝜉,𝜔, 𝜖, 𝛿ሻ ൌ 1𝜔𝑓ௌ஺ௌ ൬𝜃 െ 𝜉𝜔 ฬ 𝜖, 𝛿൰ 
where 
𝑓ௌ஺ௌሺ𝑧|𝜖, 𝛿ሻ ൌ 1ඥ2𝜋ሺ1 ൅ 𝑧ଶሻ 𝛿𝐶ఢ,ఋሺ𝑧ሻexp ቆെ𝑆ఢ,ఋଶ ሺ𝑧ሻ2 ቇ 
𝐶ఢ,ఋሺ𝑧ሻ ൌ cosh ሼ𝛿 sinhିଵሺ𝑧ሻ െ 𝜖ሽ 
𝑆ఢ,ఋሺ𝑧ሻ ൌ sinh ሼ𝛿 sinhିଵሺ𝑧ሻ െ 𝜖ሽ 
The SAS distribution can express symmetric or skewed shapes with heavy or light 
tailweight. In Figure 2(h)(i), several examples are presented. 𝜉 and 𝜔 are the location 
and scale parameters, respectively, 𝛿 ሺ൐ 0ሻ is the kurtosis parameter, and 𝜖 is the 
skewness parameter. This distribution is positively (negatively) skewed for 𝜖 ൐ 0 (𝜖 ൏0). The kurtosis is regulated by 𝛿 . It can express different shapes from the skew t-
distributions including quite sharply-peaked and gently sloped ones with various degrees 
of skewness. The mean and variance of this distribution are Eሾ𝜃ሿ ൌ  𝜉 ൅ 𝜔𝜁ఋ,ఢ Vሾ𝜃ሿ ൌ 𝜔ଶൣ𝜆ఋ,ఢ െ 𝜁ఋ,ఢଶ ൧ 
where 
𝜁ఋ,ఢ ൌ 𝑒ଵ ସ⁄√8𝜋 sinh ቀ𝜖𝛿ቁ ൜𝐾ሺଵ ఋ⁄ ାଵሻ ଶ⁄ ൬14൰ ൅ 𝐾ሺଵ ఋ⁄ ିଵሻ ଶ⁄ ൬14൰ൠ 
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𝜆ఋ,ఢ ൌ 12 ቊ𝑒ଵ ସ⁄√8𝜋 cosh ൬2𝜖𝛿 ൰ ൜𝐾ሺଶ ఋ⁄ ାଵሻ ଶ⁄ ൬14൰ ൅ 𝐾ሺଶ ఋ⁄ ିଵሻ ଶ⁄ ൬14൰ൠ െ 1ቋ 
and 𝐾௔ሺ𝑧ሻ is the modified Bessel function of the second kind 19. 
 
       For readers with interests to mathematical background of these distributions, see 
Azzalini and Capitanio 11 and Jones 20. 
 
4. Estimation and prediction 
For the random-effects model (*), we can adopt the flexible distribution models for the 
random-effects distribution 𝐹ሺ𝜃ሻ. The average treatment effect can be addressed as the 
mean μ of 𝐹ሺ𝜃ሻ. As in the conventional DerSimonian-Laird-type normal-normal model, 
the parameters of 𝐹ሺ𝜃ሻ can be estimated by frequentist methods (e.g., the maximum 
likelihood estimation), but in many cases, they require complex numerical integrations; 
the computations of confidence intervals and P-values also have computational 
difficulties. Besides, through Bayesian approaches, we can compute posterior 
distributions of the mean parameter using a unified Markov Chain Monte Carlo (MCMC) 
framework 21,22. In addition, under the Bayesian framework, we can directly assess the 
predictive distribution of the treatment effect for a future study by the posterior predictive 
distribution 5. When using the flexible parametric distributions, we can directly assess the 
nature and degree of heterogeneity by the predictive distribution. The variance of these 
distributions can be formally defined, but might not be properly interpreted as a dispersion 
parameter for skewed distributions. For these flexible skewed distributions, the predictive 
distributions can be directly used as a heterogeneity measure. Also, if we assume a non-
informative prior distribution, the posterior inference can be substantially equivalent to 
the frequentist inference. For comparisons of competing models, we can use model 
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assessment criteria of Bayesian statistics, e.g., the deviation information criterion (DIC) 
23. These computations can be easily performed by simple commands using the R package 
flexmeta. The source R and Stan codes are available at our GitHub site 
(https://github.com/nomahi/flexmeta), and the users can freely customize the prior 
distribution settings. 
In the real-data analyses in Section 5, we adopted non-informative priors; the 
default settings of flexmeta adopt the same prior distributions. For the location and scale 
parameters 𝜉 and 𝜔, we consistently adopted the following vague prior distributions for 
the seven models (including the ordinary normal and t-distribution models): 
𝜉~𝑁ሺ0, 100ଶሻ 
𝜔~𝑈ሺ0, 20ሻ 
For the degree-of-freedom 𝜈  of the t-distribution, skew t-distribution, and AS2 
distribution, we adopted an exponential (0.1) prior that was restricted to k > 2.5 to assure 
the existence of the second moment (k ≥ 2), as in 6,24. For the skewness parameter 𝛼 of 
the skew normal distribution, skew-t distribution, and AS2 distribution, we adopted a 
proper vague normal prior 𝑁ሺ0, 5ଶሻ . For the Jones–Faddy distribution, we assumed 
uniform priors for the two model parameters 𝑎 and , 𝑎, 𝑏~𝑈ሺ1.5, 200ሻ . The lower 
bound of the uniform distribution is determined to assure the existences of the first, 
second and third moments 14. For the SAS distribution, we also adopted vague priors for 
the skewness and kurtosis parameters, 𝜖~𝑁ሺ0,100ଶሻ and 𝛿~𝑈ሺ0,100ሻ. 
 
5. Applications 
We applied the flexible random-effects models to the two meta-analysis datasets 
described in Section 2. As reference methods, we also conducted the same analyses using 
the normal and t-distribution models. We used R ver. 3.5.1 and the flexmeta package for 
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the statistical analyses; to implement MCMC, we used RStan ver. 2.19.2 25. After 10000 
warm-ups, 250000 samples were used for the posterior inferences and prediction. The 
95% credible intervals (CrI) and predictive intervals (PI) were calculated using the 
posterior samples of the mean of 𝐹ሺ𝜃ሻ and the predictive distribution of the effect of a 
future study 𝜃௡௘௪~𝐹ሺ𝜃ሻ from MCMC. To evaluate the impact of adopting the flexible 
distribution models rather than the ordinary normal distribution, we present graphical 
displays of the posterior and predictive distributions. In addition, we assessed model 
adequacies by DIC. 
In Table 1 (a), we present the summary of the posterior distributions for the mean 
μ of the random-effects distributions. We adopted the posterior mean as the point 
estimator because it is derived as the Bayes optimal estimator by squared error loss 
function 21,22, but median or mode can also be adopted. For the first example, the meta-
analysis of chronic lower back pain, the posterior summary of the normal distribution is 
similar to the results of the conventional method, and the overall MD is −3.17 (95%CrI: 
−8.02, 1.73). The posterior means and 95%CrI of μ were quite different. In Figure 3, we 
present graphical displays of the 250000 posterior samples of μ. All of the estimated 
posterior distributions by the five flexible random-effects distribution models indicated 
skewed and sharply-peaked distributions; it was sharply-peaked even for the t-distribution. 
DIC comparisons suggested that the best-fitting model was the AS2 distribution (DIC = 
139.03); the SAS distribution was comparable to it (DIC = 139.97). Both of these 
distributions yielded larger MD estimates: −3.99 (95%CrI: −9.47, −0.10) and −5.33 
(95%CrI: −11.37, −0.94), respectively. In addition, the posterior probabilities that μ is 
smaller than 0 were 0.98 and 0.99, respectively, whereas that of the normal random-
effects distribution model was 0.90. In the original paper by Rubinstein et al. 16, the 
overall MD test was not statistically significant at the 5% level. However, the overall 
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results were clearly altered by adopting the skewed flexible distribution models, which 
strongly indicated that the true effect sizes would lie within a narrower range and would 
be skewed. The overall conclusion for the overall MD could be changed using the flexible 
models. Also, we present a summary of the predictive distribution of this example in 
Table 2 (a). These results also indicated that the predictive distribution would be strongly 
skewed. 
For the second example, the meta-analysis of non-alcoholic fatty liver disease, 
we present summaries of the posterior distribution of μ and the predictive distribution in 
Table 1(b) and 2(b). For this case, the normal distribution model provides results that are 
similar to those of the conventional methods. However, DIC comparisons revealed that 
the normal distribution was the worst-fitted model (DIC = 99.27), whereas AS2 and skew 
t-distribution were the best-fitted (DIC = 94.72, 95.44). For the overall MD μ, the flexible 
models exhibited more skewed posterior distributions and larger MD estimates. Further, 
in Figure 4, we present the predictive distributions of the seven distribution models. We 
found that all of the flexible distribution models exhibited skewed and sharply-peaked 
distributions. In particular, the well-fitted AS2 and skew t-distributions indicated that the 
treatment effect in a future study 𝜃௡௘௪ would lie within a narrower range and would be 
skew distributed. However, the 95%PI of the normal distribution model was (−10.71, 
3.68), while those of AS2 and skew t-distribution were (−12.96, 0.15) and (−11.53, 0.55), 
respectively. The posterior probabilities of Pr(𝜃௡௘௪ ൏ 0ሻ  of the normal distribution 
model was 0.84, whereas those of AS2 and skew t-distribution were 0.97 and 0.95, 
respectively. Hence, the overall conclusions might be altered. 
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6. Discussion 
Conclusions obtained from meta-analyses are widely applied to public health, clinical 
practice, health technology assessments, and policy-making. If misleading results have 
been produced by inadequate methods, the impact might be enormous. Conventional 
methods using inverse-variance weights might not be recommended when they are 
inappropriate. In this article, we proposed effective methods for meta-analysis using 
flexible random-effects distribution models, and provided an easily implementable 
statistical package for these methods. Through illustrative examples, we clearly showed 
the restrictions of using the conventional normal random-effects distribution model, 
which may yield misleading conclusions. The flexible random-effects distribution models 
represent a promising possibility to prevent such outcomes. Conventionally, these 
MCMC computations require special software and high-performance computers; to 
address these obstacles, we developed a user-friendly package, flexmeta, which was 
designed to be easily handled and is freely available online. The proposed methods and 
the developed tools would help us to provide precise evidence. At a minimum, we 
recommend using these methods in sensitivity analyses. 
In this study, we adopted five flexible distributions, but other probability 
distributions exist in statistical theory, e.g., see the comprehensive textbook by Azzalini 
and Capitanio 11. We chose the five distributions from unimodal tractable distribution 
families that can express flexible distribution shapes with interpretability and parsimony, 
which were well discussed in Jones 20. Other choices might also be considered, but the 
five distribution models discussed here are known to be highly flexible, and significantly 
different results are not likely to be obtained by adopting other existing distributions. 
Another choice would be to adopt nonparametric methods 21,22. However, in meta-
analysis in medical studies, the number of studies K is usually not large 26,27; consequently, 
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nonparametric methods would be unstable in many applications because they require 
much larger statistical information (parallel to K) to conduct valid estimation and 
prediction. Also, the normal distribution model implicitly involves some relevant hidden 
assumptions that were well discussed in Jackson and White 28. The fully parametric 
assumptions for a random-effects distribution similarly induces the same limitations, but 
the flexible alternative distribution assumptions address a relevant limitation “the shape 
of the normal distribution is assumed (for the random-effects distribution), not just the 
first two moments” 28. Although various methods to overcome the limitations of the 
normal distribution assumptions, there are no unique methods that address the all 
limitations discussed by Jackson and White 28 uniformly. The proposed methods in this 
paper would be useful tools that can be added as an effective tool to address these issues. 
In addition, classical transformations have been conventionally applied, but these 
methods also adopt the restrictive normal distribution assumption after the 
transformations. The posterior and predictive distributions are obtained after back-
transformations, and their statistical outputs would be intuitively more difficult to 
interpret for non-statisticians. The proposed methods have advantages in their intuitive 
comprehensibility and would have more flexibility in representability of the random-
effects distribution. Also, the back-transformation results can provide seriously 
misleading results under certain situations 9. 
In comparison of families of distributions for usual data analyses, the choice 
among alternative parametric families should be largely based on criteria other than their 
ability to fit data because of the near-equivalence of some parametric families in terms of 
fitting adequacy 11,20. However, in this situation, we adopt these distribution models as 
random-effects distributions. The possible inadequacy of the normal distribution 
assumption is a relevant problem-specific requirement, but we consider there would not 
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be certain criteria to select parametric families among the flexible distributions except for 
the ability to fit data. Thus, the Bayesian statistical criteria for evaluating model fitting 29 
would be useful in selecting the distribution model. In addition, the background 
characteristics of individual studies should be preliminary investigated before these 
analyses. Some relevant insights might be obtained, and should be carefully discussed if 
they exist. 
As shown by the real data applications, existing meta-analyses may have reached 
misleading conclusions due to the straightforward uses of the normal random-effects 
distribution model. Our proposed methods might change the overall conclusions of these 
meta-analyses, and systematic re-evaluation of existing meta-analyses would be an 
interesting topic for future studies. In addition, for future systematic reviews, the flexible 
methods might be used as standard methods to provide accurate conclusions, at least in 
sensitivity analyses. 
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Table 1. Summary of the posterior distributions for the mean μ of the random-effects distribution 16,17 †. 
Random-effects distribution Mean Median SD 1Q 3Q 95% CrI Pr(μ < 0) DIC 
(a) Meta-analysis for the treatment of chronic low back pain 
Normal distribution −3.17 −3.18 2.47 −4.79 −1.56 (−8.02, 1.73) 0.90 145.62 
t-distribution −1.43 −1.35 1.91 −2.60 −0.17 (−5.47, 2.14) 0.78 143.54 
Skew normal distribution −4.27 −4.24 2.05 −5.61 −2.90 (−8.37, −0.32) 0.98 141.91 
Skew t-distribution −3.47 −3.30 2.09 −4.73 −2.03 (−8.04, 0.19) 0.97 140.50 
AS2 distribution −3.99 −3.68 2.39 −5.34 −2.29 (−9.47, −0.10) 0.98 139.03 
Jones–Faddy distribution −3.09 −2.99 2.05 −4.35 −1.73 (−7.49, 0.65) 0.95 141.94 
Sinh–arcsinh distribution −5.33 −5.05 2.91 −6.83 −3.48 (−11.37, −0.94) 0.99 139.97 
(b) Meta-analysis for the treatment of nonalcoholic fatty liver disease 
Normal distribution −3.52 −3.53 0.77 −4.03 −3.02 (−5.04, −1.98) 1.00 99.27 
t-distribution −3.06 −3.05 0.66 −3.49 −2.62 (−4.43, −1.81) 1.00 97.95 
Skew normal distribution −3.83 −3.81 0.69 −4.26 −3.37 (−5.29, −2.55) 1.00 96.52 
Skew t-distribution −3.61 −3.57 0.69 −4.04 −3.15 (−5.14, −2.40) 1.00 95.44 
AS2 distribution −3.78 −3.86 0.83 −4.71 −3.28 (−5.72, −2.44) 1.00 94.72 
Jones–Faddy distribution −3.49 −3.47 0.68 −3.92 −3.04 (−4.93, −2.23) 1.00 97.02 
Sinh–arcsinh distribution −4.24 −4.49 0.86 −5.06 −3.89 (−6.03, −2.75) 1.00 96.70 
         
† 1Q, 3Q: 1st and 3rd quartiles, CrI: credible interval, DIC: deviance information criterion. 
 
  
 
 
 
 
 
 Table 2. Summary of the predictive distributions for the two meta-analyses 16,17 †. 
Random-effects distribution Mean Median SD 1Q 3Q 95% PI Pr(θnew< 0) 
(a) Meta-analysis for the treatment of chronic low back pain 
Normal distribution −3.17 −3.19 11.33 −10.49 4.14 (−25.62, 19.29) 0.61 
t-distribution −1.43 −1.32 9.69 −6.11 3.35 (−20.46, 17.35) 0.58 
Skew normal distribution −4.26 −2.75 9.43 −9.60 2.54 (−26.42, 9.92) 0.63 
Skew t-distribution −3.47 −1.42 9.60 −6.96 2.34 (−26.85, 8.51) 0.59 
AS2 distribution −4.22 −1.14 10.56 −7.27 2.08 (−32.22, 6.81) 0.58 
Jones–Faddy distribution −3.09 −1.66 9.65 −7.25 2.61 (−24.65, 11.22) 0.59 
Sinh–arcsinh distribution −5.37 −1.77 11.80 −9.65 1.93 (−33.51, 7.67) 0.60 
(b) Meta-analysis for the treatment of nonalcoholic fatty liver disease 
Normal distribution −3.52 −3.52 3.63 −5.88 −1.16 (−10.71, 3.68) 0.84 
t-distribution −3.06 −3.03 3.37 −4.82 −1.29 (−9.77, 3.51) 0.86 
Skew normal distribution −3.83 −3.30 3.18 −5.61 −1.55 (−11.31, 0.93) 0.93 
Skew t-distribution −3.61 −2.94 3.23 −4.93 −1.56 (−11.53, 0.55) 0.95 
AS2 distribution −3.81 −2.81 3.57 −5.01 −1.59 (−12.96, 0.15) 0.97 
Jones–Faddy distribution −3.49 −3.08 3.20 −5.10 −1.48 (−10.78, 1.72) 0.91 
Sinh–arcsinh distribution −4.31 −3.39 3.72 −6.36 −1.65 (−12.78, 0.61) 0.95 
        
† 1Q, 3Q: 1st and 3rd quartiles, PI: predictive interval. 
 
 
 
 
Figure 1. Forest plots for the two motivating examples: (a) meta-analysis of chronic low back pain 16, (b) meta-analysis of 
nonalcoholic fatty liver disease 17. The sizes of the squares are proportional to the study-specific variances. 
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Figure 2. Flexible models for the random-effects distribution: (a) skew normal distribution, (b), (c) skew t-distribution, 
(d), (e) AS2 distribution, (f), (g) Jones–Faddy distribution, (h), (i) sinh–arcsinh distribution. 
  
 
 
 
 
 
Figure 3. Posterior distributions for μ of the meta-analysis of chronic low back pain 16 using seven random-effects distribution models.  
(a) Normal distribution
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(b) t-distribution
Mean difference
D
e
n
s
i
t
y
-25 -20 -15 -10 -5 0 5 10
0
.
0
0
0
.
0
5
0
.
1
0
0
.
1
5
0
.
2
0
0
.
2
5
(c) Skew normal distribution
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(d) Skew t-distribution
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(e) Asymmetric Subbotin distribution
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(f) Jones-Faddy distribution
Mean difference
D
e
n
s
i
t
y
-25 -20 -15 -10 -5 0 5 10
0
.
0
0
0
.
0
5
0
.
1
0
0
.
1
5
0
.
2
0
0
.
2
5
(g) Sinh-arcsinh distribution
Mean difference
D
e
n
s
i
t
y
-25 -20 -15 -10 -5 0 5 10
0
.
0
0
0
.
0
5
0
.
1
0
0
.
1
5
0
.
2
0
0
.
2
5
 
 
 
 
 
 
Figure 4. Predictive distributions for the meta-analysis of nonalcoholic fatty liver disease 17 using seven random-effects distribution models. 
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(c) Skew normal distribution
Mean difference
D
e
n
s
i
t
y
-30 -20 -10 0 10 20
0
.
0
0
0
.
0
5
0
.
1
0
0
.
1
5
0
.
2
0
0
.
2
5
(d) Skew t-distribution
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e-Appendix A: Sensitivity analyses using a multilevel meta-analysis model 
As noted in Section 2, the two example datasets involve multiple outcome data for a single 
study. Rubinstein et al. (2019) actually synthesized outcome data from 18 trials, and the 
summary outcomes of 4 trials with three arms were calculated by common control arms. 
Only 1 trial with four arms reported two summary outcomes comparing separate 2 arms. 
Koutoukidis et al. (2019) also synthesized outcome data from 21 trials and the summary 
outcomes of 4 trials with three arms were calculated by common control arms. The 
original articles provide ordinary random-effects meta-analysis results ignoring the 
duplications. These analyses are essentially inadequate because the correlations among 
multiple outcome measures within a single study are not addressed (Higgins and Thomas, 
2019). These practices are still frequently observed even in current leading medical 
journals. We adopted the original datasets in the illustrative analyses for comparability 
with the original results (Koutoukidis et al., 2019; Rubinstein et al., 2019). However, we 
performed sensitivity analyses using a multilevel meta-analysis model that adequately 
address the within-study correlations by rma.mv function in R package metafor 
(Viechtbauer, 2010). The estimated overall estimates are presented in e-Table 1. The 
standard errors (SEs) were substantially larger than the results by DerSimonian-Laird and 
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Hartung-Knapp methods, but they would not change overall conclusions for both of the 
two meta-analyses. For meta-analyses datasets involving such multi-arm trials, the 
flexible probability distributions can also be adopted to the random-effects models for the 
multilevel meta-analysis models. The multilevel model analyses can be easily 
implemented by modifying the source codes of our R package flexmeta. 
 
e-Table 1. Results of the meta-analyses for the two example datasets using a multilevel meta-analysis 
model. 
 Estimate SE 95% CI P-value 
      
(a) Meta-analysis for the treatment of chronic low back pain 
DerSimonian-Laird method −3.170 2.386 −7.846 1.506 0.184 
Hartung-Knapp method −3.183 2.306 −7.965 1.600 0.181 
Multilevel meta-analysis model −4.012 2.700 −9.304 1.280 0.137 
      
(b) Meta-analysis for the treatment of nonalcoholic fatty liver disease 
DerSimonian-Laird method −3.484 0.752 −4.958 −2.009 < 0.001 
Hartung-Knapp method −3.489 0.716 −4.970 −2.008 < 0.001 
Multilevel meta-analysis model −3.870 0.813 −5.464 −2.277 < 0.001 
      
 
 
e-Appendix B: Simulation studies 
We conducted simulation studies to evaluate the performances of the proposed methods 
under practical settings. We considered the random-effects models (*) defined in Section 
3, 
𝑌𝑖~𝑁(𝜃𝑖 , 𝜎𝑖
2) 
𝜃𝑖~𝐹(𝜃) 
Here, we considered two flexible random-effects distribution models, the skew normal 
distribution and the skew t-distribution; we would address more extensive simulation 
studies using the other distribution models as further issues in future researches because 
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these methods require enormous computational burdens, but the following numerical 
results would provide certain evidence for the performances of these methods. For the 
parameter settings, we set 𝜉 = 0 without loss of generality. Also, for the scale parameter, 
we set 𝜔2 = 0.25, 0.50, and for the skewness parameter, we set 𝛼 = 2,4,6,8. For the 
degree-of-freedom for skew t-distribution, we adopted 3 and 8. Combining these settings, 
we suppose total 12 distributions. Summaries of these distributions are presented in e-
Table 2. Also, we considered two settings for the number of trials to be synthesized, K = 
12, 24; then we conducted simulation studies by total 24 scenarios. The outcome data 
were generated as binomial data, such as Xir ~ Binomial (nir, pir) (i = 1,…, K; r = 0, 1). 
For the measure of treatment effect, we considered odds ratios (ORs); i.e., θir = log [pir (1 
– pi0) / {pi0 (1 − pir)}] (r = 0, 1). The response rate of reference treatment pi0 was randomly 
generated from a continuous uniform distribution on [0.05, 0.65]. Also, the OR 
parameters θir were generated from the random-effects distributions. The sample sizes 
were set to equal one another, ni0 = ni1 for any i, and were assigned random integer values 
between 20 and 200. These settings mimicked the simulation studies of Sidik and 
Jonkman (2007). 
     We compared the performances of the proposed methods with the conventional 
DerSimonian-Laird and Hartung-Knapp methods. For performance evaluations, we first 
assessed the accuracy and precision of point estimators of mean of the random-effects 
distributions by bias and root mean squared error (RMSE). Also, we assessed coverage 
rates and expected widths of 95% confidence intervals (CIs) and credible interval (CrI) 
for the mean of the random-effects distributions. We also assessed coverage rates and 
expected widths of 95% prediction intervals (PIs) for the treatment effect of a future study, 
which is randomly generated by the random-effects distribution. For the DerSimonian-
Laird method, there are no corresponding methods for computing PI, so we adopted 
Higgins-Thompson-Spiegelhalter (Higgins, Thompson and Spiegelhalter, 2009; HTS) 
method instead of it. Also, for the Hartung-Knapp method, the point estimate corresponds 
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to the restricted maximum likelihood (REML) estimate, and PI was calculated by the 
computational method provided by Partlett and Riley (2017). We conducted 2500 
simulations for individual scenarios and computed empirical quantities for these measures. 
     The simulation results are presented in e-Table 3-12. Under most of these scenarios, 
biases of the three methods are comparable. However, under skew t-distribution with 3 
degree-of-freedom, the biases of DerSimonian-Laird and REML estimators were larger 
than the proposed methods. These results would be caused by the model misspecifications. 
Besides, the RMSEs of the DerSimonian-Laird and REML estimators were generally 
smaller than the proposed methods, even under the skew t-distribution with 3 degree-of-
freedom. The reasons of these paradoxical results were the SEs of the two estimators 
based on normal random-effects distribution models were smaller than those of the 
proposed methods. Since the overall dispersions of the skewed distribution are generally 
larger than the normal distribution, the resultant estimators can be more variable. These 
results possibly indicate the conventional estimation methods are robust for model 
misspecification for estimation of the mean parameter, and can provide favorable 
estimators by the means of RMSE. It might be an interesting subjects for theoretical 
studies in future studies. 
     Besides, for the coverage properties of CIs and CrI, the conventional two methods 
showed serious undercoverage properties under a lot of scenarios. The undercoverage 
property of the DerSimonian-Laird method is well-known even under correctly specified 
normal random-effects distribution models (Brockwell and Gordon, 2001; Veroniki et al., 
2019), but the improved Hartung-Knapp method also showed serious undercoverage 
property under the skewed distributions. The expected widths of these methods were 
markedly smaller than the proposed methods, and these methods would substantially 
underestimate statistical uncertainties. Besides, the proposed methods generally showed 
better coverage probabilities under all settings, and these were mostly around the nominal 
level (95%).  
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    For the PIs, the coverage probabilities of HTS and Hartung-Knapp methods were also 
seriously below the nominal level (95%). The possible undercoverage properties of these 
methods under moderate K setting were also reported even under correctly specified 
normal random-effects distribution models (Nagashima, Noma and Furukawa, 2019; 
Partlett and Riley, 2017). However, under the misspecified random-effects distribution 
models, the undercoverage properties were more serious. These properties would be 
caused that PI depends on the shape of predictive distribution more directly; as shown in 
Section 5. Besides, the proposed methods generally showed better coverage probabilities 
under all settings, and these were mostly around the nominal level (95%). To assess the 
statistical uncertainties accurately, the flexible random-effects distribution models would 
be more suitable if the true random-effects distributions are diverged from the normal 
distribution. 
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e-Table 2. Summary of the random-effects distributions. 
   Percentiles 
Distribution Mean SD 10th 25th 50th 75th 90th 
        
SN(0, 0.50, 2) 0.357  0.350  −0.067  0.110  0.328  0.574  0.822  
SN(0, 0.50, 4) 0.387  0.317  0.026  0.153  0.337  0.575  0.822  
SN(0, 0.50, 6) 0.394  0.308  0.049  0.158  0.337  0.575  0.822  
SN(0, 0.50, 8) 0.396  0.305  0.057  0.159  0.337  0.575  0.822  
SN(0, 0.71, 2) 0.505  0.495  −0.095  0.156  0.463  0.812  1.163  
SN(0, 0.71, 4) 0.547  0.448  0.036  0.216  0.477  0.813  1.163  
SN(0, 0.71, 6) 0.557  0.436  0.069  0.224  0.477  0.813  1.163  
SN(0, 0.71, 8) 0.560  0.432  0.080  0.225  0.477  0.813  1.163  
ST(0, 0.50, 3, 2) 0.493  0.712  −0.075  0.118  0.363  0.702  1.170  
ST(0, 0.50, 3, 4) 0.535  0.681  0.027  0.164  0.380  0.710  1.176  
ST(0, 0.50, 3, 6) 0.544  0.674  0.052  0.171  0.382  0.711  1.177  
ST(0, 0.50, 3, 8) 0.547  0.671  0.060  0.173  0.382  0.711  1.177  
ST(0, 0.71, 3, 2) 0.697  1.007  −0.105  0.167  0.513  0.993  1.654  
ST(0, 0.71, 3, 4) 0.756  0.963  0.039  0.232  0.537  1.005  1.663  
ST(0, 0.71, 3, 6) 0.769  0.953  0.073  0.242  0.540  1.006  1.664  
ST(0, 0.71, 3, 8) 0.774  0.949  0.085  0.245  0.541  1.006  1.664  
ST(0, 0.50, 8, 2) 0.395  0.421  −0.070  0.113  0.340  0.617  0.929  
ST(0, 0.50, 8, 4) 0.429  0.387  0.026  0.157  0.353  0.620  0.930  
ST(0, 0.50, 8, 6) 0.436  0.379  0.050  0.163  0.353  0.620  0.930  
ST(0, 0.50, 8, 8) 0.439  0.376  0.058  0.165  0.353  0.620  0.930  
ST(0, 0.71, 8, 2) 0.559  0.595  −0.099  0.160  0.481  0.873  1.314  
ST(0, 0.71, 8, 4) 0.606  0.547  0.037  0.222  0.499  0.877  1.315  
ST(0, 0.71, 8, 6) 0.616  0.535  0.070  0.231  0.499  0.877  1.315  
ST(0, 0.71, 8, 8) 0.620  0.531  0.082  0.233  0.499  0.877  1.315  
        
  
7 
 
 
e-Table 3. Results of the simulation studies: Bias and root mean squared error (RMSE) of the three estimators from the mean of random-effects 
distribution.  
Distribution 𝐾 
DerSimonian-Laird method  REML method  Flexible random-effects model 
Bias RMSE  Bias RMSE  Bias RMSE 
          
SN(0, 0.50, 2) 12 0.001  0.142   0.001  0.138   0.006  0.140  
SN(0, 0.50, 4) 12 0.000  0.130   −0.006  0.129   0.009  0.135  
SN(0, 0.50, 6) 12 0.001  0.130   −0.004  0.128   0.009  0.134  
SN(0, 0.50, 8) 12 0.000  0.128   −0.005  0.126   0.006  0.132  
SN(0, 0.71, 2) 12 0.004  0.172   −0.005  0.174   0.011  0.175  
SN(0, 0.71, 4) 12 −0.005  0.161   −0.003  0.162   0.006  0.163  
SN(0, 0.71, 6) 12 −0.002  0.159   −0.011  0.156   0.007  0.164  
SN(0, 0.71, 8) 12 0.001  0.161   −0.009  0.158   0.010  0.160  
ST(0, 0.50, 3, 2) 12 −0.021  0.193   −0.023  0.195   0.005  0.214  
ST(0, 0.50, 3, 4) 12 −0.016  0.188   −0.023  0.188   0.016  0.203  
ST(0, 0.50, 3, 6) 12 −0.019  0.182   −0.028  0.185   0.004  0.198  
ST(0, 0.50, 3, 8) 12 −0.017  0.183   −0.027  0.185   0.007  0.199  
ST(0, 0.71, 3, 2) 12 −0.040  0.247   −0.045  0.248   0.006  0.269  
ST(0, 0.71, 3, 4) 12 −0.042  0.236   −0.052  0.238   −0.002  0.259  
ST(0, 0.71, 3, 6) 12 −0.048  0.235   −0.053  0.235   0.004  0.256  
ST(0, 0.71, 3, 8) 12 −0.054  0.229   −0.055  0.235   −0.003  0.253  
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e-Table 4. Results of the simulation studies: Bias and root mean squared error (RMSE) of the three estimators from the mean of random-effects 
distribution. 
Distribution 𝐾 
DerSimonian-Laird method  REML method  Flexible random-effects model 
Bias RMSE  Bias RMSE  Bias RMSE 
          
ST(0, 0.50, 8, 2) 12 0.008  0.153   −0.006  0.153   0.018  0.162  
ST(0, 0.50, 8, 4) 12 0.004  0.150   −0.006  0.145   0.008  0.152  
ST(0, 0.50, 8, 6) 12 0.000  0.144   −0.005  0.143   0.009  0.150  
ST(0, 0.50, 8, 8) 12 0.000  0.140   −0.008  0.142   0.011  0.149  
ST(0, 0.71, 8, 2) 12 0.003  0.197   −0.011  0.194   0.014  0.205  
ST(0, 0.71, 8, 4) 12 −0.007  0.182   −0.010  0.183   0.022  0.197  
ST(0, 0.71, 8, 6) 12 −0.005  0.182   −0.015  0.180   0.013  0.187  
ST(0, 0.71, 8, 8) 12 −0.004  0.176   −0.012  0.178   0.008  0.189  
SN(0, 0.50, 2) 24 0.004  0.098   −0.003  0.096   0.007  0.098  
SN(0, 0.50, 4) 24 0.000  0.093   −0.005  0.092   0.006  0.096  
SN(0, 0.50, 6) 24 0.002  0.095   −0.004  0.090   0.004  0.092  
SN(0, 0.50, 8) 24 0.001  0.092   −0.005  0.090   0.005  0.094  
SN(0, 0.71, 2) 24 0.006  0.124   −0.003  0.122   0.008  0.126  
SN(0, 0.71, 4) 24 −0.002  0.111   −0.010  0.113   0.008  0.115  
SN(0, 0.71, 6) 24 0.000  0.113   −0.009  0.112   0.011  0.115  
SN(0, 0.71, 8) 24 0.000  0.113   −0.010  0.110   0.009  0.113  
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e-Table 5. Results of the simulation studies: Bias and root mean squared error (RMSE) of the three estimators from the mean of random-effects 
distribution. 
Distribution 𝐾 
DerSimonian-Laird method  REML method  Flexible random-effects model 
Bias RMSE  Bias RMSE  Bias RMSE 
          
ST(0, 0.50, 3, 2) 24 −0.018  0.138   −0.022  0.137   0.001  0.147  
ST(0, 0.50, 3, 4) 24 −0.020  0.130   −0.028  0.131   0.000  0.137  
ST(0, 0.50, 3, 6) 24 −0.018  0.129   −0.030  0.130   0.001  0.138  
ST(0, 0.50, 3, 8) 24 −0.026  0.134   −0.029  0.133   0.000  0.137  
ST(0, 0.71, 3, 2) 24 −0.044  0.177   −0.049  0.178   −0.007  0.191  
ST(0, 0.71, 3, 4) 24 −0.044  0.169   −0.057  0.172   −0.009  0.177  
ST(0, 0.71, 3, 6) 24 −0.047  0.169   −0.057  0.171   −0.013  0.176  
ST(0, 0.71, 3, 8) 24 −0.049  0.164   −0.057  0.168   −0.012  0.174  
ST(0, 0.50, 8, 2) 24 0.004  0.109   −0.003  0.109   0.012  0.114  
ST(0, 0.50, 8, 4) 24 0.000  0.103   −0.007  0.102   0.008  0.105  
ST(0, 0.50, 8, 6) 24 0.000  0.101   −0.006  0.100   0.007  0.104  
ST(0, 0.50, 8, 8) 24 0.001  0.102   −0.009  0.100   0.006  0.105  
ST(0, 0.71, 8, 2) 24 −0.004  0.137   −0.009  0.137   0.014  0.144  
ST(0, 0.71, 8, 4) 24 −0.001  0.130   −0.013  0.129   0.013  0.134  
ST(0, 0.71, 8, 6) 24 −0.001  0.129   −0.014  0.128   0.012  0.135  
ST(0, 0.71, 8, 8) 24 −0.004  0.131   −0.015  0.124   0.012  0.133  
          
 
  
10 
 
 
e-Table 6. Results of the simulation studies: Coverage rate and expected width of the 95% confidence interval or credible interval for the mean 
of random-effects distribution. 
Distribution 𝐾 
DerSimonian-Laird method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
SN(0, 0.50, 2) 12 0.916  0.533   0.950  0.602   0.964  0.661  
SN(0, 0.50, 4) 12 0.930  0.500   0.954  0.569   0.967  0.630  
SN(0, 0.50, 6) 12 0.923  0.498   0.955  0.565   0.964  0.625  
SN(0, 0.50, 8) 12 0.921  0.493   0.957  0.559   0.971  0.620  
SN(0, 0.71, 2) 12 0.917  0.655   0.948  0.744   0.966  0.835  
SN(0, 0.71, 4) 12 0.926  0.610   0.945  0.694   0.967  0.771  
SN(0, 0.71, 6) 12 0.921  0.602   0.948  0.680   0.961  0.760  
SN(0, 0.71, 8) 12 0.910  0.592   0.939  0.677   0.958  0.752  
ST(0, 0.50, 3, 2) 12 0.904  0.695   0.933  0.825   0.957  0.967  
ST(0, 0.50, 3, 4) 12 0.894  0.661   0.926  0.790   0.951  0.918  
ST(0, 0.50, 3, 6) 12 0.890  0.660   0.920  0.775   0.945  0.897  
ST(0, 0.50, 3, 8) 12 0.886  0.653   0.922  0.771   0.954  0.898  
ST(0, 0.71, 3, 2) 12 0.890  0.858   0.925  1.039   0.954  1.260  
ST(0, 0.71, 3, 4) 12 0.872  0.799   0.910  0.987   0.945  1.160  
ST(0, 0.71, 3, 6) 12 0.868  0.787   0.899  0.971   0.942  1.125  
ST(0, 0.71, 3, 8) 12 0.869  0.786   0.904  0.971   0.937  1.124  
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e-Table 7. Results of the simulation studies: Coverage rate and expected width of the 95% confidence interval or credible interval for the mean 
of random-effects distribution. 
Distribution 𝐾 
DerSimonian-Laird method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
ST(0, 0.50, 8, 2) 12 0.931  0.581   0.948  0.659   0.972  0.793  
ST(0, 0.50, 8, 4) 12 0.904  0.553   0.952  0.628   0.972  0.742  
ST(0, 0.50, 8, 6) 12 0.925  0.543   0.948  0.618   0.969  0.734  
ST(0, 0.50, 8, 8) 12 0.926  0.544   0.948  0.617   0.969  0.720  
ST(0, 0.71, 8, 2) 12 0.912  0.726   0.947  0.835   0.968  1.010  
ST(0, 0.71, 8, 4) 12 0.910  0.675   0.942  0.780   0.968  0.939  
ST(0, 0.71, 8, 6) 12 0.908  0.665   0.938  0.763   0.961  0.919  
ST(0, 0.71, 8, 8) 12 0.918  0.665   0.937  0.757   0.957  0.899  
SN(0, 0.50, 2) 24 0.935  0.379   0.953  0.401   0.953  0.417  
SN(0, 0.50, 4) 24 0.937  0.359   0.949  0.378   0.948  0.393  
SN(0, 0.50, 6) 24 0.925  0.354   0.950  0.373   0.951  0.386  
SN(0, 0.50, 8) 24 0.931  0.352   0.947  0.371   0.952  0.387  
SN(0, 0.71, 2) 24 0.935  0.470   0.949  0.500   0.947  0.526  
SN(0, 0.71, 4) 24 0.941  0.435   0.945  0.463   0.955  0.486  
SN(0, 0.71, 6) 24 0.932  0.429   0.943  0.456   0.953  0.479  
SN(0, 0.71, 8) 24 0.933  0.426   0.949  0.453   0.954  0.474  
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e-Table 8. Results of the simulation studies: Coverage rate and expected width of the 95% confidence interval or credible interval for the mean 
of random-effects distribution. 
Distribution 𝐾 
DerSimonian-Laird method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
ST(0, 0.50, 3, 2) 24 0.912  0.500   0.936  0.559   0.943  0.596  
ST(0, 0.50, 3, 4) 24 0.913  0.477   0.923  0.528   0.938  0.561  
ST(0, 0.50, 3, 6) 24 0.916  0.469   0.920  0.522   0.934  0.550  
ST(0, 0.50, 3, 8) 24 0.892  0.468   0.915  0.520   0.936  0.546  
ST(0, 0.71, 3, 2) 24 0.893  0.612   0.917  0.709   0.938  0.769  
ST(0, 0.71, 3, 4) 24 0.891  0.578   0.909  0.663   0.937  0.712  
ST(0, 0.71, 3, 6) 24 0.878  0.567   0.900  0.655   0.931  0.693  
ST(0, 0.71, 3, 8) 24 0.880  0.562   0.902  0.650   0.927  0.692  
ST(0, 0.50, 8, 2) 24 0.934  0.417   0.945  0.444   0.954  0.484  
ST(0, 0.50, 8, 4) 24 0.941  0.395   0.945  0.419   0.959  0.453  
ST(0, 0.50, 8, 6) 24 0.935  0.389   0.948  0.413   0.956  0.447  
ST(0, 0.50, 8, 8) 24 0.935  0.387   0.945  0.411   0.946  0.442  
ST(0, 0.71, 8, 2) 24 0.928  0.516   0.949  0.560   0.962  0.622  
ST(0, 0.71, 8, 4) 24 0.920  0.483   0.942  0.524   0.958  0.573  
ST(0, 0.71, 8, 6) 24 0.922  0.473   0.937  0.516   0.951  0.565  
ST(0, 0.71, 8, 8) 24 0.916  0.474   0.943  0.510   0.952  0.558  
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e-Table 9. Results of the simulation studies: Coverage rate and expected width of the 95% prediction intervals. 
Distribution 𝐾 
HTS method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
SN(0, 0.50, 2) 12 0.874  1.513   0.873  1.517   0.948  1.861  
SN(0, 0.50, 4) 12 0.869  1.361   0.867  1.363   0.957  1.735  
SN(0, 0.50, 6) 12 0.876  1.339   0.874  1.341   0.957  1.714  
SN(0, 0.50, 8) 12 0.870  1.311   0.870  1.314   0.962  1.699  
SN(0, 0.71, 2) 12 0.908  2.121   0.909  2.146   0.947  2.511  
SN(0, 0.71, 4) 12 0.901  1.909   0.901  1.931   0.950  2.267  
SN(0, 0.71, 6) 12 0.901  1.852   0.901  1.869   0.957  2.229  
SN(0, 0.71, 8) 12 0.901  1.844   0.899  1.860   0.951  2.199  
ST(0, 0.50, 3, 2) 12 0.901  2.302   0.901  2.411   0.944  2.893  
ST(0, 0.50, 3, 4) 12 0.898  2.152   0.895  2.260   0.945  2.721  
ST(0, 0.50, 3, 6) 12 0.896  2.098   0.894  2.200   0.940  2.656  
ST(0, 0.50, 3, 8) 12 0.898  2.082   0.897  2.182   0.948  2.661  
ST(0, 0.71, 3, 2) 12 0.904  2.989   0.907  3.234   0.935  3.906  
ST(0, 0.71, 3, 4) 12 0.908  2.784   0.911  3.019   0.944  3.574  
ST(0, 0.71, 3, 6) 12 0.906  2.729   0.908  2.954   0.937  3.465  
ST(0, 0.71, 3, 8) 12 0.908  2.731   0.909  2.955   0.948  3.448  
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e-Table 10. Results of the simulation studies: Coverage rate and expected width of the 95% prediction intervals. 
Distribution 𝐾 
HTS method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
ST(0, 0.50, 8, 2) 12 0.886  1.750   0.885  1.768   0.956  2.283  
ST(0, 0.50, 8, 4) 12 0.885  1.611   0.884  1.626   0.954  2.103  
ST(0, 0.50, 8, 6) 12 0.884  1.573   0.880  1.583   0.955  2.068  
ST(0, 0.50, 8, 8) 12 0.880  1.563   0.881  1.578   0.958  2.023  
ST(0, 0.71, 8, 2) 12 0.911  2.446   0.913  2.512   0.947  3.053  
ST(0, 0.71, 8, 4) 12 0.905  2.225   0.906  2.283   0.954  2.813  
ST(0, 0.71, 8, 6) 12 0.906  2.160   0.906  2.214   0.948  2.737  
ST(0, 0.71, 8, 8) 12 0.906  2.131   0.904  2.182   0.951  2.675  
SN(0, 0.50, 2) 24 0.906  1.390   0.907  1.394   0.939  1.547  
SN(0, 0.50, 4) 24 0.896  1.247   0.896  1.249   0.938  1.404  
SN(0, 0.50, 6) 24 0.894  1.210   0.892  1.213   0.935  1.371  
SN(0, 0.50, 8) 24 0.898  1.199   0.894  1.200   0.941  1.368  
SN(0, 0.71, 2) 24 0.928  1.972   0.929  1.996   0.942  2.144  
SN(0, 0.71, 4) 24 0.923  1.763   0.923  1.779   0.941  1.928  
SN(0, 0.71, 6) 24 0.923  1.720   0.923  1.736   0.952  1.889  
SN(0, 0.71, 8) 24 0.928  1.704   0.927  1.721   0.944  1.860  
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e-Table 11. Results of the simulation studies: Coverage rate and expected width of the 95% prediction intervals. 
Distribution 𝐾 
HTS method  Hartung-Knapp method  Flexible random-effects model 
Coverage rate Expected width  Coverage rate Expected width  Coverage rate Expected width 
          
ST(0, 0.50, 3, 2) 24 0.917  2.154   0.920  2.257   0.935  2.450  
ST(0, 0.50, 3, 4) 24 0.921  1.995   0.922  2.085   0.947  2.275  
ST(0, 0.50, 3, 6) 24 0.922  1.961   0.922  2.046   0.942  2.218  
ST(0, 0.50, 3, 8) 24 0.918  1.944   0.919  2.029   0.944  2.200  
ST(0, 0.71, 3, 2) 24 0.912  2.790   0.920  3.030   0.932  3.325  
ST(0, 0.71, 3, 4) 24 0.919  2.577   0.924  2.786   0.940  3.036  
ST(0, 0.71, 3, 6) 24 0.921  2.527   0.928  2.735   0.944  2.944  
ST(0, 0.71, 3, 8) 24 0.923  2.512   0.928  2.712   0.947  2.932  
ST(0, 0.50, 8, 2) 24 0.914  1.640   0.913  1.654   0.936  1.885  
ST(0, 0.50, 8, 4) 24 0.910  1.489   0.909  1.500   0.944  1.716  
ST(0, 0.50, 8, 6) 24 0.908  1.451   0.909  1.463   0.939  1.680  
ST(0, 0.50, 8, 8) 24 0.910  1.441   0.907  1.451   0.943  1.655  
ST(0, 0.71, 8, 2) 24 0.923  2.256   0.927  2.323   0.946  2.604  
ST(0, 0.71, 8, 4) 24 0.925  2.060   0.927  2.117   0.947  2.355  
ST(0, 0.71, 8, 6) 24 0.927  2.009   0.928  2.063   0.953  2.311  
ST(0, 0.71, 8, 8) 24 0.927  1.984   0.926  2.034   0.954  2.287  
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